| 0 |
HUMAN PAPILLOMA VIRUS TEST POSITIVE |
1 |
0.0025 |
| 1 |
ACNE CYSTIC |
5 |
0.0017 |
| 2 |
SOCIAL ANXIETY DISORDER |
1 |
0.0015 |
| 3 |
ACNE PUSTULAR |
1 |
0.0012 |
| 4 |
BRADYCARDIA FOETAL |
1 |
0.0012 |
| 5 |
NEONATAL RESPIRATORY DISTRESS |
1 |
0.0011 |
| 6 |
BLOOD TESTOSTERONE INCREASED |
2 |
0.0009 |
| 7 |
OSTEOCHONDROSIS |
1 |
0.0009 |
| 8 |
VESTIBULAR DISORDER |
1 |
0.0008 |
| 9 |
AGORAPHOBIA |
1 |
0.0007 |
| 10 |
CARDIOVASCULAR INSUFFICIENCY |
1 |
0.0006 |
| 11 |
TETANY |
1 |
0.0005 |
| 12 |
BLADDER SPASM |
1 |
0.0005 |
| 13 |
BACTERIAL TEST POSITIVE |
1 |
0.0004 |
| 14 |
OVARIAN HYPERSTIMULATION SYNDROME |
1 |
0.0004 |
| 15 |
PREGNANCY ON ORAL CONTRACEPTIVE |
1 |
0.0004 |
| 16 |
OTITIS MEDIA |
1 |
0.0003 |
| 17 |
SUSPECTED COUNTERFEIT PRODUCT |
1 |
0.0003 |
| 18 |
EXPOSURE VIA BREAST MILK |
1 |
0.0003 |
| 19 |
MONOPLEGIA |
1 |
0.0002 |
| 20 |
RESPIRATORY SYNCYTIAL VIRUS INFECTION |
2 |
0.0002 |
| 21 |
IRON DEFICIENCY |
1 |
0.0002 |
| 22 |
SUSPECTED OFF LABEL USE |
1 |
0.0002 |
| 23 |
GESTATIONAL DIABETES |
1 |
0.0002 |
| 24 |
INFUSION SITE SWELLING |
1 |
0.0002 |
| 25 |
PROSTATIC SPECIFIC ANTIGEN INCREASED |
2 |
0.0001 |
| 26 |
RESPIRATORY RATE INCREASED |
1 |
0.0001 |
| 27 |
GASTROINTESTINAL INFECTION |
1 |
0.0001 |
| 28 |
HYPOTONIA |
1 |
0.0001 |
| 29 |
UNINTENDED PREGNANCY |
1 |
0.0001 |
| 30 |
SPINAL PAIN |
1 |
0.0001 |
| 31 |
MUSCLE SPASTICITY |
1 |
0.0001 |
| 32 |
DYSMENORRHOEA |
1 |
0.0001 |
| 33 |
LIVER FUNCTION TEST ABNORMAL |
2 |
0.0001 |
| 34 |
URINARY RETENTION |
2 |
0.0001 |
| 35 |
CIRCULATORY COLLAPSE |
1 |
0.0001 |
| 36 |
HAEMATURIA |
2 |
0.0001 |
| 37 |
PARANOIA |
1 |
0.0001 |
| 38 |
ABDOMINAL DISTENSION |
6 |
0.0001 |
| 39 |
AMENORRHOEA |
1 |
0.0001 |
| 40 |
PELVIC PAIN |
1 |
0.0001 |
| 41 |
POST PROCEDURAL COMPLICATION |
1 |
0.0001 |
| 42 |
DYSPEPSIA |
5 |
0.0001 |
| 43 |
VAGINAL HAEMORRHAGE |
2 |
0.0000 |
| 44 |
SHOCK |
1 |
0.0000 |
| 45 |
AGEUSIA |
1 |
0.0000 |
| 46 |
BACK PAIN |
9 |
0.0000 |
| 47 |
MUCOSAL INFLAMMATION |
1 |
0.0000 |
| 48 |
CHEST PAIN |
7 |
0.0000 |
| 49 |
JAUNDICE |
1 |
0.0000 |
| 50 |
PALLOR |
1 |
0.0000 |
| 51 |
DYSSTASIA |
1 |
0.0000 |
| 52 |
ASCITES |
1 |
0.0000 |
| 53 |
ABDOMINAL PAIN UPPER |
7 |
0.0000 |
| 54 |
PREMATURE BABY |
1 |
0.0000 |
| 55 |
ABDOMINAL PAIN |
7 |
0.0000 |
| 56 |
ANGER |
1 |
0.0000 |
| 57 |
DRUG EXPOSURE DURING PREGNANCY |
1 |
0.0000 |
| 58 |
PANIC ATTACK |
1 |
0.0000 |
| 59 |
ALOPECIA |
5 |
0.0000 |
| 60 |
FOETAL EXPOSURE DURING PREGNANCY |
2 |
0.0000 |
| 61 |
WITHDRAWAL SYNDROME |
1 |
0.0000 |
| 62 |
MENTAL DISORDER |
1 |
0.0000 |
| 63 |
CONSTIPATION |
5 |
0.0000 |
| 64 |
COVID-19 |
4 |
0.0000 |
| 65 |
THERAPEUTIC RESPONSE UNEXPECTED |
1 |
0.0000 |
| 66 |
SKIN DISCOLOURATION |
1 |
0.0000 |
| 67 |
UPPER RESPIRATORY TRACT INFECTION |
1 |
0.0000 |
| 68 |
HYPOGLYCAEMIA |
1 |
0.0000 |
| 69 |
MALIGNANT NEOPLASM PROGRESSION |
2 |
0.0000 |
| 70 |
MUSCULOSKELETAL PAIN |
1 |
0.0000 |
| 71 |
DRUG INTERACTION |
3 |
0.0000 |
| 72 |
TREATMENT NONCOMPLIANCE |
1 |
0.0000 |
| 73 |
NECK PAIN |
1 |
0.0000 |
| 74 |
EYE PAIN |
1 |
0.0000 |
| 75 |
PLEURAL EFFUSION |
1 |
0.0000 |
| 76 |
VERTIGO |
1 |
0.0000 |
| 77 |
MUSCLE SPASMS |
3 |
0.0000 |
| 78 |
NASOPHARYNGITIS |
3 |
0.0000 |
| 79 |
VISUAL IMPAIRMENT |
2 |
0.0000 |
| 80 |
EXPOSURE DURING PREGNANCY |
1 |
0.0000 |
| 81 |
INFUSION RELATED REACTION |
1 |
0.0000 |
| 82 |
BLOOD PRESSURE DECREASED |
1 |
0.0000 |
| 83 |
HYPOAESTHESIA |
2 |
0.0000 |
| 84 |
INJECTION SITE SWELLING |
1 |
0.0000 |
| 85 |
PARAESTHESIA |
2 |
0.0000 |
| 86 |
TREMOR |
2 |
0.0000 |
| 87 |
INTENTIONAL PRODUCT USE ISSUE |
1 |
0.0000 |
| 88 |
SUICIDAL IDEATION |
1 |
0.0000 |
| 89 |
CARDIAC DISORDER |
1 |
0.0000 |
| 90 |
SYNCOPE |
1 |
0.0000 |
| 91 |
ERYTHEMA |
2 |
0.0000 |
| 92 |
NAUSEA |
7 |
0.0000 |
| 93 |
DEPRESSION |
2 |
0.0000 |
| 94 |
PALPITATIONS |
1 |
0.0000 |
| 95 |
INJECTION SITE ERYTHEMA |
1 |
0.0000 |
| 96 |
DIZZINESS |
4 |
0.0000 |
| 97 |
LOSS OF CONSCIOUSNESS |
1 |
0.0000 |
| 98 |
HYPERHIDROSIS |
1 |
0.0000 |
| 99 |
DIARRHOEA |
5 |
0.0000 |
| 100 |
RENAL FAILURE |
1 |
0.0000 |
| 101 |
INSOMNIA |
2 |
0.0000 |
| 102 |
WEIGHT DECREASED |
2 |
0.0000 |
| 103 |
ANXIETY |
2 |
0.0000 |
| 104 |
PAIN IN EXTREMITY |
2 |
0.0000 |
| 105 |
DRUG DEPENDENCE |
1 |
0.0000 |
| 106 |
CONFUSIONAL STATE |
1 |
0.0000 |
| 107 |
URINARY TRACT INFECTION |
1 |
0.0000 |
| 108 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
1 |
0.0000 |
| 109 |
DYSPNOEA |
3 |
0.0000 |
| 110 |
HEADACHE |
3 |
0.0000 |
| 111 |
WEIGHT INCREASED |
1 |
0.0000 |
| 112 |
DECREASED APPETITE |
1 |
0.0000 |
| 113 |
FEELING ABNORMAL |
1 |
0.0000 |
| 114 |
COUGH |
1 |
0.0000 |
| 115 |
CONDITION AGGRAVATED |
1 |
0.0000 |
| 116 |
INJECTION SITE PAIN |
1 |
0.0000 |
| 117 |
ARTHRALGIA |
1 |
0.0000 |
| 118 |
DRUG INEFFECTIVE |
3 |
0.0000 |
| 119 |
VOMITING |
1 |
0.0000 |
| 120 |
OFF LABEL USE |
1 |
0.0000 |